PX
FY2026 EPS Estimate
$1.09
FY2026E EPS$1.09
FY2027E EPS$1.26

Analyst Sentiment

Wall St. Consensus
Hold
8 analysts·Limited coverage
59
Score
4 Buy (50%)3 Hold (38%)1 Sell (12%)
Rating Breakdown
Strong Buy
00%
Buy
450%
Hold
338%
Sell
113%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$12.00
+58.9%
Consensus
$12.50
+65.6%
Bull
$25.00
+231.1%
12-Month Target Range8 analysts
$12.00$12.50$25.00
Current $7.55Consensus
Current Price
$7.55
Upside to Consensus
$4.95

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+11.41%
EPS+15.88%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$351M$391M
Low$341M$385M
High$361M$397M
EBITDA Avg$115M$128M
Low$112M$126M
High$118M$130M
EBIT Avg$68M$76M
Low$66M$75M
High$70M$77M
Net Income Avg$515M$597M
Low$506M$575M
High$524M$619M
EPS Avg$1.09$1.26
Low$1.07$1.22
High$1.11$1.31
Analysts (Rev / EPS)2 / 21 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$86M$91M$91M$98M$102M$105M
Low$86M$91M$91M$98M$102M$105M
High$86M$91M$91M$98M$102M$105M
EBITDA Avg$28M$30M$30M$32M$33M$34M
Low$28M$30M$30M$32M$33M$34M
High$28M$30M$30M$32M$33M$34M
EBIT Avg$17M$18M$18M$19M$20M$20M
Low$17M$18M$18M$19M$20M$20M
High$17M$18M$18M$19M$20M$20M
Net Income Avg$34M$35M$36M$40M$41M$43M
Low$34M$35M$36M$40M$41M$43M
High$34M$35M$36M$40M$41M$43M
EPS Avg$0.28$0.29$0.31$0.33$0.35$0.36
Low$0.28$0.29$0.31$0.33$0.35$0.36
High$0.28$0.29$0.31$0.33$0.35$0.36
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jan 20, 2026Oppenheimer
P10 price target raised to $25 from $22 at Oppenheimer
Target:$25.00
+128.1%from $10.96
Nov 7, 2025Oppenheimer
P10 price target raised to $22 from $21 at Oppenheimer
Target:$22.00
+106.2%from $10.67
Oct 8, 2025Barclays
P10 price target lowered to $13 from $14 at Barclays
Target:$13.00
+18.7%from $10.95
Oct 10, 2024Morgan Stanley
P10 price target raised to $12 from $10 at Morgan Stanley
Target:$12.00
+7.9%from $11.12
Oct 7, 2024Barclays
P10 price target raised to $12 from $11 at Barclays
Target:$12.00
+8.6%from $11.05
Aug 12, 2024Stephens
P10 price target raised to $12 from $10 at Stephens
Target:$12.00
+29.0%from $9.30
Jul 8, 2024Oppenheimer
P10 Inc (PX) PT Raised to $13 at Oppenheimer
Target:$13.00
+55.7%from $8.35
Apr 20, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on P10, Lowers Price Target to $16
Target:$16.00
+33.2%from $12.01
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.